170 related articles for article (PubMed ID: 35406371)
1. Elucidation of Focal Adhesion Kinase as a Modulator of Migration and Invasion and as a Potential Therapeutic Target in Chronic Lymphocytic Leukemia.
Burley TA; Hesketh A; Bucca G; Kennedy E; Ladikou EE; Towler BP; Mitchell S; Smith CP; Fegan C; Johnston R; Pepper A; Pepper C
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406371
[TBL] [Abstract][Full Text] [Related]
2. PYK2 is overexpressed in chronic lymphocytic leukaemia: A potential new therapeutic target.
Sbrana FV; Fiordi B; Bordini J; Belloni D; Barbaglio F; Russo L; Scarfò L; Ghia P; Scielzo C
J Cell Mol Med; 2023 Feb; 27(4):576-586. PubMed ID: 36747338
[TBL] [Abstract][Full Text] [Related]
3. The Role of the Microenvironment and Cell Adhesion Molecules in Chronic Lymphocytic Leukemia.
Cerreto M; Foà R; Natoni A
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958334
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen.
Bailón E; Ugarte-Berzal E; Amigo-Jiménez I; Van den Steen P; Opdenakker G; García-Marco JA; García-Pardo A
J Leukoc Biol; 2014 Aug; 96(2):185-99. PubMed ID: 25080557
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of NF-κB-mediated signaling by the cyclin-dependent kinase inhibitor CR8 overcomes prosurvival stimuli to induce apoptosis in chronic lymphocytic leukemia cells.
Cosimo E; McCaig AM; Carter-Brzezinski LJ; Wheadon H; Leach MT; Le Ster K; Berthou C; Durieu E; Oumata N; Galons H; Meijer L; Michie AM
Clin Cancer Res; 2013 May; 19(9):2393-405. PubMed ID: 23532892
[TBL] [Abstract][Full Text] [Related]
6. Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.
Mittal AK; Chaturvedi NK; Rai KJ; Gilling-Cutucache CE; Nordgren TM; Moragues M; Lu R; Opavsky R; Bociek GR; Weisenburger DD; Iqbal J; Joshi SS
Mol Med; 2014 Jul; 20(1):290-301. PubMed ID: 24800836
[TBL] [Abstract][Full Text] [Related]
7. Focal adhesion kinase-dependent activation of the early endocytic protein Rab5 is associated with cell migration.
Arriagada C; Silva P; Millet M; Solano L; Moraga C; Torres VA
J Biol Chem; 2019 Aug; 294(34):12836-12845. PubMed ID: 31292193
[TBL] [Abstract][Full Text] [Related]
8. MMP-9 affects gene expression in chronic lymphocytic leukemia revealing CD99 as an MMP-9 target and a novel partner in malignant cell migration/arrest.
Aguilera-Montilla N; Bailón E; Uceda-Castro R; Ugarte-Berzal E; Santos A; Gutiérrez-González A; Pérez-Sánchez C; Van den Steen PE; Opdenakker G; García-Marco JA; García-Pardo A
Oncogene; 2019 Jun; 38(23):4605-4619. PubMed ID: 30760844
[TBL] [Abstract][Full Text] [Related]
9. Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migration.
Pasikowska M; Walsby E; Apollonio B; Cuthill K; Phillips E; Coulter E; Longhi MS; Ma Y; Yallop D; Barber LD; Patten P; Fegan C; Ramsay AG; Pepper C; Devereux S; Buggins AG
Blood; 2016 Jul; 128(4):563-73. PubMed ID: 27252234
[TBL] [Abstract][Full Text] [Related]
10. CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motility.
Girbl T; Hinterseer E; Grössinger EM; Asslaber D; Oberascher K; Weiss L; Hauser-Kronberger C; Neureiter D; Kerschbaum H; Naor D; Alon R; Greil R; Hartmann TN
Cancer Res; 2013 Jan; 73(2):561-70. PubMed ID: 23117883
[TBL] [Abstract][Full Text] [Related]
11. The Nedd8-activating enzyme inhibitor MLN4924 thwarts microenvironment-driven NF-κB activation and induces apoptosis in chronic lymphocytic leukemia B cells.
Godbersen JC; Humphries LA; Danilova OV; Kebbekus PE; Brown JR; Eastman A; Danilov AV
Clin Cancer Res; 2014 Mar; 20(6):1576-89. PubMed ID: 24634471
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells.
Purroy N; Carabia J; Abrisqueta P; Egia L; Aguiló M; Carpio C; Palacio C; Crespo M; Bosch F
Oncotarget; 2017 Jan; 8(1):742-756. PubMed ID: 27888629
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen.
Bailón E; Ugarte-Berzal E; Amigo-Jiménez I; Van den Steen P; Opdenakker G; García-Marco JA; García-Pardo A
J Leukoc Biol; 2014 Mar; ():. PubMed ID: 24620030
[TBL] [Abstract][Full Text] [Related]
14. Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765.
Herman SE; Gordon AL; Hertlein E; Ramanunni A; Zhang X; Jaglowski S; Flynn J; Jones J; Blum KA; Buggy JJ; Hamdy A; Johnson AJ; Byrd JC
Blood; 2011 Jun; 117(23):6287-96. PubMed ID: 21422473
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cell migration by focal adhesion kinase: Time-dependent difference in integrin-induced signaling between endothelial and hepatoblastoma cells.
Yu H; Gao M; Ma Y; Wang L; Shen Y; Liu X
Int J Mol Med; 2018 May; 41(5):2573-2588. PubMed ID: 29484384
[TBL] [Abstract][Full Text] [Related]
16. Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia.
van Attekum MHA; Terpstra S; Slinger E; von Lindern M; Moerland PD; Jongejan A; Kater AP; Eldering E
Oncogene; 2017 Jun; 36(26):3651-3660. PubMed ID: 28192408
[TBL] [Abstract][Full Text] [Related]
17. An impaired transendothelial migration potential of chronic lymphocytic leukemia (CLL) cells can be linked to ephrin-A4 expression.
Trinidad EM; Ballesteros M; Zuloaga J; Zapata A; Alonso-Colmenar LM
Blood; 2009 Dec; 114(24):5081-90. PubMed ID: 19828693
[TBL] [Abstract][Full Text] [Related]
18. Focal adhesion kinase mediates cell survival via NF-kappaB and ERK signaling pathways.
Huang D; Khoe M; Befekadu M; Chung S; Takata Y; Ilic D; Bryer-Ash M
Am J Physiol Cell Physiol; 2007 Apr; 292(4):C1339-52. PubMed ID: 17135301
[TBL] [Abstract][Full Text] [Related]
19. MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by alpha4beta1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration.
Redondo-Muñoz J; Escobar-Díaz E; Samaniego R; Terol MJ; García-Marco JA; García-Pardo A
Blood; 2006 Nov; 108(9):3143-51. PubMed ID: 16840734
[TBL] [Abstract][Full Text] [Related]
20. Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation.
Ringelstein-Harlev S; Avivi I; Fanadka M; Horowitz NA; Katz T
Cancer Immunol Immunother; 2018 May; 67(5):739-748. PubMed ID: 29450641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
